Evidence map›Paper›PMID 25531831›Full record

ArticleNature immunology2015

Role and species-specific expression of colon T cell homing receptor GPR15 in colitis.

Linh P Nguyen, Junliang Pan, Theresa Thanh Dinh, Husein Hadeiba, Edward O'Hara, Ahmad Ebtikar, Arnulf Hertweck, M Refik Gökmen, Graham M Lord, Richard G Jenner and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. GPR15-guided CD8Nature · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Linh P NguyenDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Junliang PanThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System and The Palo Alto Veterans Institute for Research, Palo Alto, California 94304, USA.
Theresa Thanh DinhLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
Husein HadeibaThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System and The Palo Alto Veterans Institute for Research, Palo Alto, California 94304, USA.
Edward O'HaraThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System and The Palo Alto Veterans Institute for Research, Palo Alto, California 94304, USA.
Ahmad EbtikarThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System and The Palo Alto Veterans Institute for Research, Palo Alto, California 94304, USA.
Arnulf HertweckUCL Cancer Institute, University College London, London, W1T 4JF, United Kingdom.
M Refik GökmenDepartment of Experimental Immunobiology and NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' Hospital and King's College London, London, SE1 9RT, United Kingdom.
Graham M LordDepartment of Experimental Immunobiology and NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' Hospital and King's College London, London, SE1 9RT, United Kingdom.
Richard G JennerUCL Cancer Institute, University College London, London, W1T 4JF, United Kingdom.
Eugene C Butcher *The Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System and The Palo Alto Veterans Institute for Research, Palo Alto, California 94304, USA.
Aida Habtezion *Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Palo Alto Veterans Institute for Research · USKing's College London · GBStanford University · USUniversity College London · GB

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Proteomics/GenomicsP30DK056339 · NIDDK · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2001 to 2010
$10.4M
T32 Training Program in Mechanisms and Innovation in Vascular DiseaseT32HL098049 · NHLBI · STANFORD UNIVERSITY · PI Nicholas James Leeper, Philip S Tsao · 2010 to 2026
$6.3M
Intestinal Lymphocyte TraffickingR37AI047822 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2011 to 2020
$3.5M
The Role of Thymic Homing Dendritic Cells in Oral ToleranceR01AI109452 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI HADEIBA, HUSEIN · 2014 to 2018
$1.8M
Lymphocyte Homing Mechanisms in Normal & Inflamed ColonK08DK069385 · NIDDK · STANFORD UNIVERSITY · PI HABTEZION, AIDA · 2006 to 2010
$714k
Trafficking mechanisms of locally generated colon antigen reactive T cellsR03DK085426 · NIDDK · STANFORD UNIVERSITY · PI HABTEZION, AIDA · 2010 to 2011
$143k
Specificity and mechanisms of lung lymphocyte homingF32AI082924 · NIAID · STANFORD UNIVERSITY · PI NGUYEN, LINH PHUONG · 2009 to 2010
$98k
Cancer Research UK G0802068Medical Research Council G0802068NHLBI NIH HHS T32 HL098049NIAID NIH HHS 1F32 AI082924NIAID NIH HHS AI109452ANIAID NIH HHS F32 AI082924NIAID NIH HHS R01 AI109452NIAID NIH HHS R37 AI047822NIAID NIH HHS T32 AI007290NIAID NIH HHS T32 AI07290NIDDK NIH HHS DK56339NIDDK NIH HHS K08 DK069385NIDDK NIH HHS P30 DK056339NIDDK NIH HHS R03 DK085426Wellcome Trust 091009
6 · The paper itself

Abstract

Lymphocyte recruitment maintains intestinal immune homeostasis but also contributes to inflammation. The orphan chemoattractant receptor GPR15 mediates regulatory T cell homing and immunosuppression in the mouse colon. We show that GPR15 is also expressed by mouse TH17 and TH1 effector cells and is required for colitis in a model that depends on the trafficking of these cells to the colon. In humans GPR15 is expressed by effector cells, including pathogenic TH2 cells in ulcerative colitis, but is expressed poorly or not at all by colon regulatory T (Treg) cells. The TH2 transcriptional activator GATA-3 and the Treg-associated transcriptional repressor FOXP3 robustly bind human, but not mouse, GPR15 enhancer sequences, correlating with receptor expression. Our results highlight species differences in GPR15 regulation and suggest it as a potential therapeutic target for colitis.

Indexed as

Gene Expression RegulationAnimalsCells, CulturedColitisColonDisease Models, AnimalEnhancer Elements, GeneticForkhead Transcription FactorsGene Knockout TechniquesHumansMiceProtein BindingReceptors, G-Protein-CoupledReceptors, Lymphocyte HomingReceptors, PeptideSpecies SpecificityForkhead Transcription FactorsGPR15 protein, humanGpr15 protein, mouseReceptors, G-Protein-CoupledReceptors, Lymphocyte HomingReceptors, Peptide

Identifiers

PMID25531831
PMCPMC4338558
OpenAlexW1998935634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.